title: Role of molecular imaging in stem cell therapy for myocardial restoration.
abstract: During the past two decades, stem cells have created enthusiasm as a regenerative therapy for ischemic heart disease. Transplantation of bone marrow stem cells, skeletal myoblasts, and endothelial progenitor cells has shown to improve myocardial function after infarction. Recently, attention has focused on the potential use of embryonic stem cells and induced pluripotent stem cells because they possess the capacity to differentiate into various cell types, including cardiac and endothelial cells. Clinical trials have shown positive effects on the functional recovery of heart after myocardial infarction and have answered questions on timing, dosage, and cell delivery route of stem cells such as those derived from bone marrow. Despite the current advances in stem cell research, one main hurdle remains the lack of reliable information about the fate of cell engraftment, survival, and proliferation after transplantation. This review discusses the different cell types used in cardiac cell therapy as well as molecular imaging modalities relevant to survival issues.
authors.affiliation: Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA.
authors.forename: Maarten A
authors.initials: MA
authors.lastname: Lijkwan
authors.forename: Ernst Jan
authors.initials: EJ
authors.lastname: Bos
authors.forename: Joseph C
authors.initials: JC
authors.lastname: Wu
authors.forename: Robert C
authors.initials: RC
authors.lastname: Robbins
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D008163:Luminescent Measurements; D008279:Magnetic Resonance Imaging; D057054:Molecular Imaging / Q000295:instrumentation*; D009203:Myocardial Infarction / Q000175:diagnosis / Q000628:therapy*; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000628:therapy*; D049268:Positron-Emission Tomography; D033581:Stem Cell Transplantation / Q000379:methods*